21063 ⎘
Medicinal preparations containing antigens or antibodies; Vertebrate antigens Antigens related to auto-immune diseases; Preparations to induce self-tolerance
Compositions for treating inflammation and uses thereof
#302Personalized Site-Specific Immunomodulation
#303Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions
#304Antigen-specific tolerance and compositions for induction of same
#305TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
#306TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS
#307Compositions and methods for inducing immune tolerance
#308Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif
#309Cyclic peptides for the treatment of Graves' disease
#310METHODS AND COMPOSITIONS OF TREATING AUTOIMMUNE DISEASES
#311RNA for treatment of autoimmune diseases
#312ASSAY TO MEASURE THE POTENCY OF RECEPTOR-LIGAND INTERACTIONS IN NANOMEDICINES
#313Redirected, genetically-engineered T regulatory cells and their use in suppression of autoimmune and inflammatory disease
#314THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1
#315METHODS OF TREATING GRAFT VERSUS HOST DISEASE (GVHD) OR EPIDERMOLYSIS BULLOSA (EB) WITH EXOSOMES
#316Compositions and Methods for Antigen-Specific Tolerance
#317GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
#318USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
#319IL-23-P19 VACCINES
#320Methods and compositions for treating multiple sclerosis and related disorders
#321MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE
#322Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
#323Erythrocyte-binding therapeutics
#324METHODS OF IMMUNE MODULATION AGAINST FOREIGN AND/OR AUTO ANTIGENS
#325Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance
#326PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES
#327REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#328Engineered Fc constructs
#329IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#330Methods for treating chronic lymphocytic leukemia (CLL)
#331C5 IMMUNIZATION FOR AUTOLOGOUS ANTI-C5 ANTIBODY PRODUCTION
#332Compositions and methods of chimeric autoantibody receptor T cells
#333Compositions and methods of chimeric autoantibody receptor T cells
#334Compositions and methods of chimeric autoantibody receptor T cells
#335COMPOSITIONS AND METHODS FOR TREATMENT OF TYPE 1 DIABETES
#336Immunomodulatory pharmaceutical compositions
#337Compositions and methods of chimeric autoantibody receptor T cells
#338Low dose immune checkpoint blockade in metastatic cancer
#339Glycolipid compositions and methods of use
#340Covalent polymer-antigen conjugated particles
#341Peptide vaccines against interleukin-31
#342Composition for inducing proliferation or accumulation of regulatory T cells
#343Composition for inducing proliferation or accumulation of regulatory T cells
#344Methods and compositions for inducing an immune response
#345Peptide conjugated particles for the treatment of inflammation
#346Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#347Detection and treatment of demyelinating diseases
#348NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED ALLERGENIC ANTIGEN OR AN AUTOIMMUNE SELF-ANTIGEN
#349Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
#350Vaccine
#351METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
#352Treatment of canine atopic dermatitis
#353Use of specific regulatory T-cells to induce immune tolerance
#354Methods for treating autoimmune diseases incorporating an anti-LAG3 antibody
#355PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#356COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS
#357Regulatory T cell epitopes, compositions and uses thereof
#358Regulatory T cell epitopes, compositions and uses thereof
#359PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
#360COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#361Methods to Treat Diseases with Protein, Peptide and Antigen Modification
#362Acetylcholine receptor-specific immunosuppressive compositions and methods of treatment of myasthenia gravis
#363Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
#364COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES
#365Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE
#366Method and system for protecting honey bees from fipronil pesticides
#367COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MOLECULES DERIVED FROM MICROBIOTA FOR TREATMENT OF DISEASE
#368METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES
#369Immunogenic CD1d binding peptides
#370Method for vaccination against a self-antigen in a human patient
#371TOFACITINIB AS VACCINATION IMMUNE MODULATOR
#372Compositions and methods for treating an inflammatory disease or disorder
#373Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#374Treatment of immune disease by mucosal delivery of antigens using genetically modified
#375TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED IMMUNE ACTIVATION
#376Nanoparticle compositions for sustained therapy
#377KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#378Methods and compositions for sustained immunotherapy
#379Method and apparatus for microneedle transdermal delivery
#380THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS
#381Composition for inducing proliferation or accumulation of regulatory T cells
#382T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof
#383IMMUNE CELL SELECTION, EXPANSION, AND USE
#384Regulatory T cell epitopes, compositions and uses thereof
#385Regulatory T cell epitopes, compositions and uses thereof
#386Composition for inducing proliferation or accumulation of regulatory T cells
#387Inducible regulatory t-cell generation for hematopoietic transplants
#388Compositions and methods for the treatment of type 1 diabetes
#389Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
#390Therapeutic immune modulation by stem cell secreted exosomes
#391Antigen-specific T cells for inducing immune tolerance
#392IMMUNOMODULATORY PROTEINS
#393Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
#394TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#395TOLEROGENIC DENDRITIC CELLS, METHODS OF PRODUCING THE SAME, AND USES THEREOF
#396Use of modified Fc fragments in immunotherapy
#397Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#398Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#399N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#400EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#401Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
#402COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS
#403Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection
#404Transforming growth factor-beta-responsive polypeptides and their methods for use
#405Antibodies against novel PD1 isoforms and uses thereof
#406Peptide Selection Method
#407Glycotargeting therapeutics
#408Immunomodulatory pharmaceutical compositions and methods of use thereof
#409Oral dissolving films
#410Antigen-specific, tolerance-inducing microparticles and uses thereof
#411POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
#412Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies
#413Regulatory T cell epitopes, compositions and uses thereof
#414Regulatory T cell epitopes, compositions and uses thereof
#415Regulatory T cell epitopes, compositions and uses thereof
#416Regulatory T cell epitopes, compositions and uses thereof
#417Regulatory T cell epitopes, compositions and uses thereof
#418Regulatory T cell epitopes, compositions and uses thereof
#419Regulatory T cell epitopes, compositions and uses thereof
#420ANTI-PAD2 ANTIBODY FOR TREATING AND EVALUATING RHEUMATOID ARTHRITIS
#421Method of treating lupus by administering humanized anti-CXCR5 (C-X-C motif chemokine receptor 5) antibodies
#422Aluminum based adjuvants for tolerogenic vaccination
#423Multi-epitopic construct
#424Peptide conjugated particles
#425Microbial consortium and uses thereof
#426Systems for producing cellular immunotherapeutics and methods of use thereof
#427COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION
#428TECHNOLOGY FOR CONTROLLING IMMUNE CELLS
#429CD127 expression inversely correlates with FoxP3 and suppressive function of CD4 Tregs
#430DNA vaccines encoding heat shock proteins
#431NOVEL IMMUNOGENIC PEPTIDES
#432METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY
#433Multi-peptide composition
#434Motile Sperm Domain Containing Protein 2 and Inflammation
#435METHOD FOR TREATING IFNALPHA RELATED CONDITIONS
#436Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens
#437Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#438Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#439Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.
#440Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#441Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#442CD40L binding polypeptide
#443POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER
#444GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
#445Transdermal patch with separated regions for delivery of immunomodulators
#446Antigen-specific tolerance and compositions for induction of same
#447Compositions for generation of immune tolerance to specific antigens
#448Compositions for inducing antigen-specific tolerance
#449COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#450Nanoparticle-Based Antigen Specific Immunotherapy
#451Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
#452Composition for inducing proliferation or accumulation of regulatory T cells
#453Humanized antibodies
#454RECOMBINANT pMHC CLASS II MOLECULES
#455Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying Treg cells to produce therapeutic vaccine for treatment of diabetes type 1
#456Tolerogenic DNA Vaccine
#457IL-23-p19 vaccines
#458Therapeutic pooled blood apoptotic cell preparations and uses thereof
#459Erythrocyte-binding therapeutics
#460Lymph node-targeting nanoparticles
#461METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
#462Protein-based T-cell receptor knockdown
#463MATRIX-EMBEDDED TOLERANCE-PROMOTING ADJUVANTS FOR SUBCUTANEOUS IMMUNOTHERAPY
#464TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS
#465IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#466Antigen specific Tregs and related compositions, methods and systems
#467Polyelectrolyte multilayers assembled from immune signal compounds
#468ADMINISTRATION OF PLANT EXPRESSED ORAL TOLERANCE AGENTS
#469COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#470Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
#471Attenuated bacteria and methods of using
#472Cyclic di-AMP induction of type I interferon
#473TOLEROGENIC COMPOSITIONS AND METHODS
#474COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA
#475Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
#476Tolerogenic dendritic cells, methods of producing the same, and uses thereof
#477FcRn-TARGETED ANTIGEN FUSION PROTEINS
#478COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#479Anti-IL-6 vaccine composition
#480METHODS OF PREDICTING RESPONSE TO TREATMENT WITH ANTI-TNFalpha BIOLOGICAL INHIBITORS
#481Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
#482Cytokine-based fusion proteins for treatment of immune disorders
#483Immunosuppressive blood cells and methods of producing the same
#484Modified virus-like particles of CMV
#485Cytokines and neuroantigens for treatment of immune disorders
#486Peptide conjugated particles
#487Methods and compositions for treating multiple sclerosis and related disorders
#488CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
#489CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
#490Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
#491DNA-peptide combination vaccine
#492Peptide conjugated particles
#493Methods of Treating Graft Versus Host Disease (GVHD) or Epidermolysis Bullosa (EB)
#494Low dose immune checkpoint blockade in metastatic cancer
#495COMPOSITIONS AND METHODS FOR TREATING B CELL MEDIATED AUTOIMMUNE DISORDERS
#496Methods and compositions for T cell generation and uses thereof
#497IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#498METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN
#499Discovery of regulatory T cells programmed to suppress an immune response
#500Methods and compositions for modulating T-GM cell function
#501Modulated immunodominance therapy
#502Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same
#503KIF20A epitope peptides for TH1 cells and vaccines containing the same
#504METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#505NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#506Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
#507Local engineering of the lymph node environment to promote immune tolerance
#508TARGETED ADAPTIVE VACCINES
#509Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
#510Compositions and methods for inducing immune tolerance
#511Microneedle-based transdermal delivery system and method of making same
#512Allergy inhibitor compositions and kits and methods of using the same
#513Methods and compositions for treating autoimmune and inflammatory conditions
#514Method for identifying and obtaining activated T-cells that have a demethylated Foxp3 TSDR region
#515MODULATED IMMUNODOMINANCE THERAPY
#516Induction of mucosal tolerance to antigens
#517Nanoparticle compositions for sustained therapy
#518ALLERGEN FOR PROPHYLACTIC TREATMENT OF ALLERGY
#519Composition for inducing proliferation or accumulation of regulatory T cells
#520HIGHLY SOLUBLE AQUAPORIN-4 EXTRACELLULAR LOOP C PEPTIDE IMMUNIZATION FOR TREATMENT OF NEUROMYELITIS OPTICA
#521Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto
#522PRENATAL THERAPY TO INDUCE IMMUNE TOLERANCE
#523Method and system for reducing the likelihood of a spirochetes infection in a human being
#524Erythrocyte-binding therapeutics
#525Compositions and methods of chimeric autoantibody receptor T cells
#526AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS
#527MODULATED IMMUNODOMINANCE THERAPY
#528MODULATED IMMUNODOMINANCE THERAPY
#529MODULATED IMMUNODOMINANCE THERAPY
#530MODULATED IMMUNODOMINANCE THERAPY
#531COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS
#532COMPOSITIONS COMPRISING GLUTEN PEPTIDES AND USES THEREOF
#533Nanospheres encapsulating bioactive material and method for formulation of nanospheres
#534BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING
#535Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
#536Method for treating ocular inflammation
#537Bifunctional conjugate compositions and associated methods
#538Compositions and methods for treating immunological dysfunction
#539DNA vaccines encoding heat shock proteins
#540Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
#541COMPOSITIONS WITH REDUCED DIMER FORMATION
#542Methods for reducing immune responses
#543Enhancing T cell activation using altered MHC-peptide ligands
#544THERAPEUTIC IMMUNE MODULATION BY STEM CELL SECRETED EXOSOMES
#545Compositions for inducing antigen-specific tolerance
#546Methods for induction of antigen-specific immune tolerance
#547Compositions for generating immune tolerance by targeting erythrocytes
#548MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE
#549CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#550Liposome-based immunotherapy
#551Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
#552Programming of cells for tolerogenic therapies
#553Aquaporin tolerizing vaccines and methods of use thereof
#554Autoimmune antigens and cancer
#555DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS
#556METHOD FOR RESTORING IMMUNE TOLERANCE IN VIVO
#557Tolerogenic synthetic nanocarriers for allergy therapy
#558COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#559Methods of treating allergies and autoimmune diseases with homogenate of axenic
#560Adjuvant composition, adjuvant preparation containing same, and kit
#561Methods of using myelin basis protein peptide compositions
#562Tolerogenic synthetic nanocarriers
#563COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS
#564Use of specific regulatory T-cells to induce immune tolerance
#565Immunogenic peptides and their use in immune disorders
#566Methods and compositions for inhibiting diseases of the central nervous system
#567Use of immune suppressive domains as medicaments
#568TROPHOBLAST DERIVED MICROPARTICLES FOR TREATING ISCHEMIC TISSUE AND WOUNDS
#569COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#570Human monocyte sub-population for treatment of eye diseases and disorders
#571APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#572METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS
#573Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule
#574INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS
#575Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
#576Hydrophobic Preparations
#577Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#578Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
#579Attenuated bacteria and methods of using
#580Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein
#581IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR TREATING DISEASE WITH MODIFIED HOST DEFENSE PEPTIDES
#582GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
#583Aquaporin-4 Peptide Compositions and Methods of Use
#584USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS
#585COMPOSITIONS AND METHODS FOR TREATMENT OF TYPE 1 DIABETES
#586Methods and compositions of treating autoimmune diseases
#587Compositions with reduced dimer formation
#588Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#589Compositions for treatment and/or prevention of autoimmune disorders
#590COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES
#591Regulatory T cell epitopes, compositions and uses thereof
#592Methods for treating chronic lymphocytic leukemia (CLL)
#593Local engineering of the lymph node environment to promote immune tolerance
#594TOLEROGENIC SYNTHETIC NANOCARRIERS FOR T-CELL-MEDIATED AUTOIMMUNE DISEASE
#595TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#596Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#597Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#598IMMUNOGENIC FRAGMENTS OF T-CELL RECEPTOR CONSTANT DOMAINS AND PEPTIDES DERIVED THEREFROM
#599PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES
#600Cyclic di-AMP induction of type I interferon